Latest in News & Research

Rash, Itch After COVID Vaccine Rare & Quickly Resolves

By Robert Preidt (HealthDay News) | | June 23, 2021

Medicaid Enrollment Reaches Record High During Pandemic

Surge in enrollment during pandemic means that a quarter of the U.S. population is now covered by the public program
By Physician's Briefing Staff | | June 22, 2021

Poll: Many 'High-Risk' Americans Unconcerned About Skin Cancer

AAD survey revealed that 49 percent of respondents were more worried about avoiding sunburn than preventing skin cancer
By Physician’s Briefing Staff | | June 22, 2021

Risk Factors for PHACE Syndrome ID'd in Infantile Hemangiomas

Surface area of 25 cm
By Physician’s Briefing Staff | | June 17, 2021

Animal Study Offers Hope for a Better Herpes Treatment

By Alan Mozes (HealthDay News) | | June 17, 2021

Skin Rashes May Indicate Positive Test for SARS-CoV-2

17 percent of individuals report skin rashes as first presentation and 21 percent report rashes as only clinical sign of COVID-19
By Dermsquared Editorial Team | | June 16, 2021

Risk for Some Adverse Pregnancy Outcomes Up With Hidradenitis Suppurativa

In fully adjusted model, women with hidradenitis suppurativa have increased odds of spontaneous abortion, GDM, C-section
By Dermsquared Editorial Team | | June 16, 2021

Higher BMI Linked to Increased Risk for Developing Psoriasis

Hazard ratio increased for overweight, obese class 1, obese class 2/3 compared with those with BMI <25.0 kg/m
By Physician's Briefing Staff | | June 16, 2021

FDA Approves StrataGraft for Deep Partial-Thickness Thermal Burns

Data show StrataGraft helps reduce the amount of healthy skin needed for grafting
By Physician’s Briefing Staff | | June 16, 2021

Are Women Absorbing Toxins From Their Makeup?

By Physician’s Briefing Staff
By Dennis Thompson (HealthDay News) | | June 15, 2021

Third Dose of COVID Vaccine Boosts Protection in Transplant Recipients

By Physician’s Briefing Staff
By Robert Preidt (HealthDay News) | | June 15, 2021

Narrowband UVB, Topical Steroid Combo Superior for Vitiligo

Combination treatment superior to topical corticosteroids alone, but target patch treatment success only 27 percent with combination
By Dermsquared Editorial Team | | June 09, 2021

SARS-CoV-2 Not Detected in Surgical Electrocautery Plume

No virus was recovered from electrocautery performed using cell titer glow measurement for replicating virus
By Dermsquared Editorial Team | | June 09, 2021

Second-Opinion Strategy Analyzed for Cutaneous Melanocytic Lesions

Decision-analytic model shows selective second-opinion strategy could increase diagnostic accuracy, decrease population-level costs
By Physician’s Briefing Staff | | June 09, 2021

Barriers to Physician Skin Exam ID'd for Young Melanoma Survivors

Barriers to health care access linked to increased odds of suboptimal physician skin examination adherence
By Physician’s Briefing Staff | | June 09, 2021

Gap Between Mortality in Rural and Urban Areas Has Increased

Difference increased in age-adjusted mortality rates between large metropolitan areas, rural areas from 1999 to 2019
By Physician’s Briefing Staff | | June 08, 2021

Drop in Kawasaki Disease Seen During the COVID-19 Pandemic

Incidence decreased sharply after implementation of nonpharmaceutical interventions, such as mask wearing; seasonal pattern absent
By Physician’s Briefing Staff | | June 08, 2021

Real-World Study Shows Power of Pfizer, Moderna Vaccines to Prevent COVID-19

Symptomatic and asymptomatic infection reduced by 81 percent after partial vaccination and by 91 percent after full vaccination
By Physician’s Briefing Staff | | June 08, 2021

Dermatologists Receptive to AI, AuI for Diagnosis of Skin Lesions

Implementation challenges include disruption of the human physician-patient relationship, threats to accuracy
By Dermsquared Editorial Team | | June 02, 2021

Review Links Topical Calcineurin Inhibitors With Lymphoma Risk

No association seen between topical calcineurin inhibitor use and cancer overall compared with nonactive comparators
By Dermsquared Editorial Team | | June 02, 2021

NIH Starts Trial Assessing 'Mix & Match' COVID Vaccine Approach

By Physician’s Briefing Staff | | June 02, 2021

Telehealth Is Growing in Use, Acceptance Among Americans: Poll

By Robert Preidt (HealthDay News) | | June 01, 2021

ASCO: Nivolumab, Relatlimab Combo Slows Advanced Melanoma

Median progression-free survival of 10.1 versus 4.6 months seen among those receiving combo versus nivolumab alone, respectively
By Physician’s Briefing Staff | | May 28, 2021

24 of 1200